Extrawell Pharmaceutical Holdings' (HKG:858) Earnings Might Be Weaker Than You Think
Aug 04
Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedAug 14, 2025
DataAggregated Company Financials
Companies38
- 7D2.8%
- 3M56.1%
- 1Y82.1%
- YTD87.8%
The Pharma is pretty flat in the last 7 days, but Hansoh Pharmaceutical Group has stood out, gaining 4.6%. As for the the longer term, the industry is up 73% over the past 12 months. Earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 14 Aug 2025 | HK$799.6b | HK$475.7b | HK$29.1b | 11.8x | 27.5x | 1.7x |
| Sat, 12 Jul 2025 | HK$666.7b | HK$475.6b | HK$28.8b | 11.2x | 23.2x | 1.4x |
| Mon, 09 Jun 2025 | HK$617.9b | HK$476.0b | HK$28.7b | 11.4x | 21.5x | 1.3x |
| Wed, 07 May 2025 | HK$509.3b | HK$470.8b | HK$28.8b | 10.5x | 17.7x | 1.1x |
| Fri, 04 Apr 2025 | HK$502.7b | HK$468.2b | HK$28.7b | 10.1x | 17.5x | 1.1x |
| Sun, 02 Mar 2025 | HK$436.2b | HK$461.6b | HK$31.8b | 8.4x | 13.7x | 0.9x |
| Tue, 28 Jan 2025 | HK$413.8b | HK$464.0b | HK$32.0b | 8.6x | 12.9x | 0.9x |
| Thu, 26 Dec 2024 | HK$437.9b | HK$460.1b | HK$31.7b | 8.5x | 13.8x | 1x |
| Sat, 23 Nov 2024 | HK$433.1b | HK$462.7b | HK$31.5b | 8x | 13.8x | 0.9x |
| Mon, 21 Oct 2024 | HK$504.7b | HK$472.2b | HK$32.8b | 7.8x | 15.4x | 1.1x |
| Wed, 18 Sep 2024 | HK$434.9b | HK$473.4b | HK$32.9b | 7.4x | 13.2x | 0.9x |
| Fri, 16 Aug 2024 | HK$439.5b | HK$465.4b | HK$33.3b | 7.5x | 13.2x | 0.9x |
| Sun, 14 Jul 2024 | HK$432.6b | HK$458.8b | HK$32.6b | 7.4x | 13.3x | 0.9x |
| Tue, 11 Jun 2024 | HK$474.5b | HK$463.7b | HK$33.9b | 8.4x | 14x | 1x |
| Thu, 09 May 2024 | HK$476.4b | HK$464.3b | HK$33.8b | 8.3x | 14.1x | 1x |
| Sat, 06 Apr 2024 | HK$440.9b | HK$465.1b | HK$36.5b | 7.2x | 12.1x | 0.9x |
| Mon, 04 Mar 2024 | HK$446.1b | HK$470.8b | HK$33.5b | 7.9x | 13.3x | 0.9x |
| Wed, 31 Jan 2024 | HK$410.4b | HK$473.6b | HK$33.9b | 7x | 12.1x | 0.9x |
| Fri, 29 Dec 2023 | HK$483.7b | HK$473.6b | HK$33.9b | 7.7x | 14.2x | 1x |
| Sun, 26 Nov 2023 | HK$513.1b | HK$472.5b | HK$32.3b | 7.3x | 15.9x | 1.1x |
| Tue, 24 Oct 2023 | HK$422.4b | HK$469.0b | HK$31.5b | 6.7x | 13.4x | 0.9x |
| Thu, 21 Sep 2023 | HK$426.9b | HK$469.5b | HK$31.6b | 6.8x | 13.5x | 0.9x |
| Sat, 19 Aug 2023 | HK$423.2b | HK$445.8b | HK$28.2b | 9.3x | 15x | 0.9x |
| Mon, 17 Jul 2023 | HK$481.2b | HK$447.5b | HK$28.0b | 9.4x | 17.2x | 1.1x |
| Wed, 14 Jun 2023 | HK$506.8b | HK$447.5b | HK$27.8b | 9.4x | 18.2x | 1.1x |
| Fri, 12 May 2023 | HK$547.1b | HK$452.6b | HK$28.4b | 9x | 19.3x | 1.2x |
| Sun, 09 Apr 2023 | HK$544.7b | HK$454.0b | HK$28.9b | 9.4x | 18.9x | 1.2x |
| Tue, 07 Mar 2023 | HK$610.0b | HK$442.8b | HK$33.9b | 10.9x | 18x | 1.4x |
| Thu, 02 Feb 2023 | HK$629.8b | HK$448.7b | HK$35.8b | 10.6x | 17.6x | 1.4x |
| Sat, 31 Dec 2022 | HK$594.7b | HK$443.6b | HK$35.0b | 11.1x | 17x | 1.3x |
| Mon, 28 Nov 2022 | HK$576.4b | HK$437.6b | HK$34.1b | 9.5x | 16.9x | 1.3x |
| Wed, 26 Oct 2022 | HK$542.9b | HK$511.3b | HK$38.7b | 8.6x | 14x | 1.1x |
| Fri, 23 Sep 2022 | HK$499.8b | HK$516.6b | HK$40.3b | 9x | 12.4x | 1x |
| Sun, 21 Aug 2022 | HK$567.1b | HK$511.6b | HK$50.8b | 7.7x | 11.2x | 1.1x |
Price to Earnings Ratio
11.2x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 26.5x which is higher than its 3-year average PE of 15.6x.
- The 3-year average PS ratio of 1.1x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 17% per year over the last three years,
- Revenues have also declined 2.5% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 2.67% | |
| Healthcare | 1.09% | |
| Pharma | 2.82% | |
| Pharma | 2.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$38.06 | 4.6% +HK$9.9b | 115.3% | PE47.3x | |
| 1093 CSPC Pharmaceutical Group | HK$10.72 | 6.6% +HK$7.5b | 82.6% | PE26.7x | |
| 1177 Sino Biopharmaceutical | HK$7.71 | 2.8% +HK$3.8b | 155.3% | PE65.6x | |
| 867 China Medical System Holdings | HK$13.76 | 4.3% +HK$1.4b | 107.9% | PE18.8x | |
| 3933 United Laboratories International Holdings | HK$15.22 | 3.5% +HK$1.0b | 77.0% | PE10.3x |
